Currently predicting for Thu, 4 Jun 2026

GERN Prediction Chart

GERN Predictions History

Latest community submissions for GERN.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 11, 2025 $1.13 -2.39% $1.25 X 90.58% 0
Nov 11, 2025 $1.18 +1.49% $1.25 V 94.19% 1
Nov 11, 2025 Bullish $1.25 V 1
Nov 10, 2025 Bullish $1.16 V 1
Jul 23, 2025 $1.24 -2.85% $1.33 X 93.50% 0
Jul 23, 2025 $1.30 +1.78% $1.33 V 97.95% 1
Jul 23, 2025 Bullish $1.33 V 1
Mar 3, 2025 $1.84 +4.47% $1.71 X 92.47% 0
Mar 3, 2025 $1.81 +2.80% $1.71 X 94.20% 0
Mar 3, 2025 $1.76 +0.00% $1.71 V 97.08% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GERN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GERON CORPORATION
Geron
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE